January 31 – February 2, 2023 | London
The 7th Microbiome Movement – Drug Development Summit Europe will unite Europe’s leading drug developers and microbiome experts to share their latest discoveries on microbiome functionality, translation, clinical development, biomarker discovery and manufacturing scale-up.
From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel the industry forward, expanding across a wide range of diseases. Joining an outstanding line-up of speakers, Beacon’s own Research Analyst, Costanza Gorini, will be:
- Outlining key leaders in the space and overall highlights of the year, including regulatory developments
- Exploring the progression of the preclinical and clinical landscapes within drug development, and
- Giving an analysis of the trial landscape, comparing this past year to the last 10-years and exploring future outlooks for 2023
At a time where both FDA and TGA milestone regulatory approvals are shaping the microbiome-based therapeutic landscape, this flagship meeting really is a must-attend for your 2023 calendar. Get your copy of the agenda to find out why!
